The Drug Check eTEN Project

Drug CheckThe objective of the Drug Check project is to validate an on-line, pan-European service, which gathers, organises, stores, makes available and presents information and data covering pharmaceuticals and their interactions. The service provides a user-friendly, reliable, intelligent and fast mechanism to accept questions and advanced queries, process them and offer accurate answers justified with the relevant bibliography, in order to assist healthcare professionals in making the proper decisions on medication prescriptions and pharmaceutical treatments both in and out of the hospital without interrupting healthcare delivery.

The service will be offered as a web-based/mobile application to healthcare professionals and institutions (e.g. hospitals, research organisations) following the ASP (application service provider) model, and its functionality will facilitate users to gain optimum access to the service at any time, from any place using various devices (computer, mobile phones, etc), at low cost and with enhanced userfriendliness and usability, in order to become a fast, reliable, accurate and effective companion to their everyday practise. A consortium of academic experts, IT integrators and Consulting companies will offer the service via Internet and mobile platforms to healthcare professionals.

It is envisaged that the service, after its deployment, will be an invaluable companion to a wide range of healthcare professionals, by enhancing their skills and empowering their decision-making processes, thus reducing unwanted effects and improving cost-effectiveness of patients' treatment and therefore contributing to better healthcare services for all citizens.

The DrugCheck service can be a valuable tool to all healthcare professionals who want fast access to trusted and verified information (through latest bibliography and publications) about potential interactions between pharmaceuticals. The service is not limited to the information offered from the drug's documentation provided from the company but offers information on mechanisms and results of interactions between pharmaceuticals.

DrugCheck service offers the following functionality:

  • Drug Interactions: The service describes the various types of interactions between pharmaceuticals (and also nutritional elements).
  • Detailed description of the interaction mechanism and the mechanism in case of special patients groups, location of interaction, pharmacokinetic properties etc.
  • Reference to the necessity of the measurement of the levels of some of the medicines already administered or scheduled to be administered to the patient, in order to decide the right dose of the medicine to minimise the risk of potential interactions
  • Effect of interaction and management of effects
  • References to source of knowledge (bibliography) and links to documentation.

For further information, please visit:
http://www.drug-check.org

Most Popular Now

Philips Introduces ClarifEye Augmented R…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced ClarifEye Augmented Reality Surgical Navigation, an industry-first solution to advance minimally-invasive spine procedures in the Hybrid...

Artificial Intelligence in the Real Worl…

Royal Bolton NHS Foundation Trust has been much praised for its deployment of AI in the fight against Covid-19. Rizwan Malik, divisional medical director of the trust and managing director...

Senior Nurse adds to Clinical Expertise …

A senior nurse with more than 20 years' experience in the NHS has joined smart health tech provider Alcidion in a core role as a clinical consultant primarily working with...

Wearable Devices can Detect COVID-19 Sym…

Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first...

EU4Health: MEPs Reach Deal with Council …

The new EU health programme, worth 5.1 billion EUR, will help to fix shortcomings exposed by COVID-19 and boost quality and resilience of EU health systems. Parliament negotiators agreed on a...

Philips completes the acquisition of Bio…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote...

Bury, Oldham, Rochdale and Trafford Go L…

Nearly half a million children's health records across Bury, Oldham, Rochdale and Trafford have been successfully integrated onto a new child health information system to support services in each area. The...

Computational Medicine - Moving from Unc…

Individual choices in medicine carry a certain amount of uncertainty. An innovative partnership at The University of Texas at Austin takes aim at medicine down to the individual level by applying...

A Machine-Learning Approach to Finding T…

When the COVID-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments. There was little time to spare. "Making new drugs takes forever," says Caroline Uhler...

Cybersecurity in Healthcare: HubIT Final…

17 February 2021, Online. The online international workshop "Cybersecurity within Healthcare Systems" takes place on the 17 of February 2021 from 10-13 am CET. The aim of this workshop is to...

Researchers Develop Data Tool that may I…

With the aid of sophisticated machine learning, researchers at UPMC and the University of Pittsburgh School of Medicine demonstrated that a tool they developed can rapidly predict mortality for patients...